Curated News
By: NewsRamp Editorial Staff
April 09, 2024
Vivos Therapeutics CEO Announces Medicare Approval for Unique Sleep Apnea Treatment Devices
Discuss on Reddit
Substack
GithubTLDR
- Vivos Therapeutics has secured Medicare reimbursement approval for their unique oral medical devices, giving them a significant advantage in the global market.
- Vivos's oral medical devices are designed to enhance the human airway, potentially eliminating sleep apnea symptoms after a 12-month treatment period.
- The approval for Medicare reimbursement for Vivos's devices is expected to benefit tens of millions of Medicare patients suffering from moderate to severe obstructive sleep apnea, transforming patient care for individuals suffering from sleep apnea.
- Vivos Therapeutics' FDA clearance positions their medical devices as the only line of oral medical devices globally that can treat severe sleep apnea, making them a pioneer in the industry.
Impact - Why it Matters
<p>The approval for Medicare reimbursement for Vivos's oral medical devices is significant as it provides a new alternative for millions of Medicare patients suffering from sleep apnea. This development has the potential to transform patient care for individuals with sleep apnea, offering a unique and effective treatment option. With recent recalls in the CPAP market, Vivos's FDA clearance comes at a crucial time, providing hope for improved patient care and treatment.</p>
Summary
Vivos Therapeutics CEO Kirk Huntsman shares news of Medicare approval for their oral medical devices designed to treat sleep apnea. The unique design of Vivos's devices enhances the airway and potentially eliminates sleep apnea symptoms after 12 months, positioning them as the only oral medical devices globally that can treat severe sleep apnea. This FDA clearance is seen as a monumental achievement, benefiting millions of Medicare patients and providing a viable alternative to traditional CPAP treatments.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Vivos Therapeutics CEO Announces Medicare Approval for Unique Sleep Apnea Treatment Devices
